Battle Card: CGT Global Appoints Dr. Branagan
CGT Global just tapped Dr. Andrew Branagan to de-risk trials & boost GMP. Use this trigger to pitch Clinical Trial Management & Outsourcing and close more deals.
Published on
Do not index
Do not index
🚀 Battle Card: CGT Global
Quick trigger:
This CGT Global sales trigger signals a push into deeper clinical advisory—time to leverage it.
👤 Decision Maker in the News
- Dr. Andrew Branagan, Board Advisor · 🔗 LinkedIn
💡 Why It Matters
- Taps world-class immunology and hematologic oncology expertise to de-risk cell & gene therapy trials and accelerate pipeline decisions. → Source
🎯 Core Pain Point
- De-risking clinical trial design for hematologic malignancies
- Scaling GMP manufacturing readiness for next-gen therapies
💰 What to Pitch
- Primary: Clinical Trial Management Platform → Faster protocol approvals & real-time data visibility
- Expansion: GMP Manufacturing Outsourcing Services → On-demand capacity at scale
🗺️ Quick Context
- HQ: Folsom, CA
- Employees: ≈ 200
- Rev: ≈ $60 M
- Website: cgt.global
🤼 Competitive Intel
*Which other vendors you’ll probably face to win CGT Global’s business.*
- Lonza — GMP Manufacturing
- Unique edge: Global multi-modal production sites
- Evaluated by VP Ops for scale & compliance
- Catalent — Biologics & Cell Therapy Manufacturing
- Unique edge: Integrated fill-finish expertise
- Evaluated by Head of Manufacturing for speed to market
- WuXi AppTec — Clinical Trial Support & Manufacturing
- Unique edge: End-to-end outsourced development
- Evaluated by Dir. R&D for cost efficiencies
- Medpace — Clinical Trial Management
- Unique edge: In-house lab & regulatory teams
- Evaluated by CMO for protocol complexity
- ICON — Clinical Trial Management
- Unique edge: Global patient recruitment network
- Evaluated by VP Clinical for enrollment speed
✅ Do-Now Checklist
Connect with Dr. Andrew Branagan on LinkedIn (link above)
Craft first touch email + DM using Copy-My-Prompt block (Step 7)
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Remember this CGT Global sales trigger when mapping your next outreach.
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑Clinical Trial Management Platform❑
PROOF_METRIC = ❑Reduced approval time by 30%❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Dr. Andrew Branagan
COMPANY = CGT Global
DEPT = Board of Advisors
SIZE = ≈ 8
BOTTLENECK = De-risking clinical trial design
EVENT = Appoints Dr. Andrew Branagan to Board of Advisors
DETAIL = your appointment of Dr. Andrew Branagan
PAIN = need to de-risk trial designs
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250806825904&div=41152219
SIM_CO = Novartis
WIN_METRIC = 30% faster protocol approvals
NEXT_SIZE = ≈ 12
EMP_EST = ≈ 200
REV_EST = ≈ $60M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 8-person Board of Advisors
Dr. Andrew Branagan—noticed your Board of Advisors team is ≈ 8.
That’s when De-risking clinical trial design slows growth.
We helped Novartis fix this with Clinical Trial Management Platform.
Result: 30% faster protocol approvals.
Quick call?
PS—next bottleneck hits ≈ 12.
DM ≤45 words, TONE:
Saw your post about your appointment of Dr. Andrew Branagan — need to de-risk trial designs.
Clinical Trial Management Platform. Reduced approval time by 30%.
Quick chat?